Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

119 results about "Glycosphingolipid" patented technology

Glycosphingolipids are a subtype of glycolipids containing the amino alcohol sphingosine. They may be considered as sphingolipids with an attached carbohydrate. Glycosphingolipids are a group of lipids (more specifically, sphingolipids) and are a part of the cell membrane. They consist of a hydrophobic ceramide part and a glycosidically bound carbohydrate part. This oligosaccharide content remains on the outside of the cell membrane where it is important for biological processes such as cell adhesion or cell–cell interactions. Glycosphingolipids play also important role in oncogenesis and ontogenesis.

Double-layer essence with repair and anti-aging functions, method for preparing double-layer essence and application thereof

The invention belongs to the technical field of cosmetics, and particularly discloses double-layer essence with repair and anti-aging functions. The double-layer essence comprises, by weight, 1.0%-2.0% of PEG-40 (polyethylene glycol-40) hydrogenated castor oil, 5%-19% of methyl trimethicone, 4%-6% of dicaprylyl carbonate, 0.5%-1.5% of cetyl dimethicone, 0.5%-1.5% of helianthus annuus seed oil, 3%-9% of glycerin, 0.1%-0.15% of sodium hyaluronate, 0.5%-1.5% of myrothamnus flabellifolia leaf/stem extract, 1%-3% of polypeptides with palmitoyl tripeptide-1 and palmitoyl tetrapeptide-7, 0.5%-1.5% of lactobacillus ferment lysate, 1%-3% of glycosphingolipid, 0.8%-1% of mixtures of glycerol caprylate, p-hydroxy phenyl ethyl ketone and glyceryl laurate and the balance water. The double-layer essence has the advantages that the double-layer essence which is a novel ultralow-viscosity double-layer system is unique in structure and convenient to use; formulas and structures of the double-layer essence are optimized, and accordingly the double-layer essence is free of potential irritation and allergy sources such as perfume and preservatives, is in mild and non-irritant formulas and has the excellent repair and anti-aging functions.
Owner:GUANGDONG MARUBI BIOLOGICAL TECH CO LTD

Pharmaceutical formulations employing short-chain sphingolipids and their use

This invention pertains to pharmaceutical formulations which comprise (i) a drug (e.g., an amphiphilic drug) (e.g., an anthracycline) (e.g., doxorubicin) and (ii) a short-chain sphingolipid (e.g., a short-chain glycosphingolipid or a short-chain sphingomyelin) (e.g., N-octanoyl-glucosylceramide, referred to as C8-GlcCer) (e.g., N-hexanoyl-sphingomyelin, referred to herein as C6-SM), and which provide improved drug delivery and efficacy. The short-chain sphingolipidis selected from compounds of the following formula: wherein: R1 is independently: an O-linked saccharide group; or an O-linked polyhydric alcohol group; or: R1 is independently: an O-linked (optionally N-(C1-4alkyl)-substituted amino)-C1-6alkyl-phosphate group; or an O-linked (polyhydric alcohol-substituted)-C1-6alkyl-phosphate group; R2 is independently C3-9alkyl, and is independently unsubstituted or substituted; R3 is independently C7-19alkyl, and is independently unsubstituted or substituted; R4 is independently —H, —OH, or —O—C1-4alkyl; RN is independently —H or C1-4alkyl; the bond marked with an alpha (α) is independently a single bond or a double bond; if the bond marked with an alpha (α) is a double bond, then R5 is —H; if the bond marked with an alpha (α) is a single bond, then R5 is —H or —OH; the carbon atom marked (*) is independently in an R-configuration or an S-configuration; the carbon atom marked (**) is independently in an R-configuration or an S-configuration; and pharmaceutically acceptable salts, solvates, esters, ethers, chemically protected forms thereof. In one embodiment, the pharmaceutical formulation is a liposomal pharmaceutical formulation prepared using a mixture of lipids comprising, at least, vesicle-forming lipids (e.g., phospholipids) (e.g., phosphatidylcholines) (e.g., fully hydrogenated soy phosphatidylcholine (HSPC)) (e.g., dipalmitoyl-phosphatidylcholine (DPPC)) and said short-chain sphingolipid, and optionally cholesterol and optionally a vesicle-forming lipid which is derivatized with a polymer chain (e.g., a phosphatidylethanolamine (PE) which is derivatized with polyethyleneglycol (PEG)) (e.g., N-(carbonyl-methoxypolyethylene glycol 2000)-1,2-distearoyl-sn-glycero-3-phosphoethanolamine sodium salt (MPEG2000-DSPE). The present invention also pertains to methods for the preparation and use of such formulations.
Owner:NETHERLANDS CANCER INST

Roe essence cream and preparation method thereof

InactiveCN109464361AGrowth inhibitionAchieve the effect of preservativesCosmetic preparationsToilet preparationsVegetable oilLycium chinense fruit extract
The invention discloses a roe essence cream and a preparation method thereof. The roe essence cream comprises a component A, a component B and a component C, wherein the component A mainly comprises 28.90-87.05 parts of purified water and 3-10 parts of butanediol according to the weight ratio; the component B mainly comprises 3-10 parts of hydrogenated vegetable oil and 0.2-2.0 parts of squalane according to the weight ratio; and the component C mainly comprises 3-10 parts of aloe barbadensis leaf juice, 0.3-3.0 parts of dendrobium stem extract, 0.3-3.0 parts of aloe barbadensis leaf extract,0.3-3.0 parts of sophora japonica root extract, 0.3-3.0 parts of lycium chinense fruit extract and 0.1-1.0 parts of sturgeon caviar extract according to the weight ratio. The roe essence cream disclosed by the invention has the advantages that moisturizing and nourishing effects are achieved by using polyols, moisturizing factors, such as glycosphingolipids, trehalose and glycine betaine, and compositions of squalane, vitamin E and the like; under coordination of active components such as high-content roe essences, dendrobium stem and wolfberry extract, the skin texture is comprehensively improved, the damaged skin is repaired, sufficient nutrient is provided, the repairing and anti-oxidant ability is developed, and the skin ageing process is relieved in a targeted manner.
Owner:GUANGZHOU ADDITIVE FREE COSMETIC CO LTD

Skin soothing regenerating protein film cream and preparation method thereof

The invention relates to skin soothing and regenerating protein film cream and a preparation method of the skin soothing regenerating protein film cream, relating to the technical field of cosmetics. The skin soothing regenerating protein film cream is prepared from the following components: water, neopentyl glycol diheptanoate, butanediol, glycerol, an oat extract, fucogel-1, glycosphingolipids, wheat fine powder lipid, a plankton extract, a mirabilis jalapa extract, a hydrolyzed egg shell membrane and the like. The skin soothing regenerating protein film cream can permeate to the stratum corneum of skin and form a reticular protective film in the skin, so that the problems of ultraviolet ray invasion and skin dryness and ageing can be solved, meanwhile, the synthesis of collagens from fibroblasts is promoted, therefore, the formation of skin wrinkles is reduced, the skin aging is resisted, the skin elasticity is improved, the skin is enabled to be tender, fine and smooth, as well as full and plump, and is full of beautiful youth gloss, the outside contamination resistance of the skin is enhanced, the self-protection ability of the skin is enhanced, the cell ageing is prevented, and thus the skin ageing is delayed, the youthful vigor of the skin is recovered, the skin is tender and full, and the beautiful skin with the real lasting health is realized from inside to outside.
Owner:广州雷诺生物科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products